180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement
Yahoo! Finance
Priced At-The-Market Under Nasdaq RulesPALO ALTO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the “Company”), a clinical-stage biotechnology company, today announced that it has entered into a definitive agreement with a single healthcare-focused U.S. institutional investor, for the purchase and sale of 1,570,680 shares of the Company’s common stock (or common stock equivalents in lieu thereof) in a registered direct offering and warra
Continue Reading